Lord, Abbett & Co
SILK

Lord, Abbett & Co’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Lord, Abbett & Co’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-795,766
Closed -$31.1M – 598
2023
Q1 		$31.1M Sell
795,766
-130,106
-14% -$6.36M 0.11% 267
2022
Q4 		$48.9M Buy
925,872
+560,131
+153% +$27.3M 0.17% 165
2022
Q3 		$16.5M Buy
+365,741
New +$15.7M 0.06% 346
2021
Q1 		– Sell
-234,240
Closed -$14.8M – 706
2020
Q4 		$14.8M Sell
234,240
-881,356
-79% -$54.7M 0.04% 462
2020
Q3 		$75M Buy
1,115,596
+794,399
+247% +$43.4M 0.24% 125
2020
Q2 		$13.5M Buy
321,197
+11,649
+4% +$447K 0.05% 431
2020
Q1 		$9.74M Sell
309,548
-3,214
-1% -$129K 0.04% 438
2019
Q4 		$12.6M Sell
312,762
-59,240
-16% -$2.07M 0.04% 479
2019
Q3 		$12.1M Buy
372,002
+91,183
+32% +$3.63M 0.04% 495
2019
Q2 		$13.6M Buy
+280,819
New +$11.9M 0.04% 498

Other funds holding SILK

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Lord, Abbett & Co's SILK Position: Q2 2023 in Review

Lord, Abbett & Co sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q2 2023, closing a stake of 795,766 shares — an estimated $31.1M sold.

Lord, Abbett & Co first reported a position in SILK in Q2 2019 and held it in 10 quarters. The position peaked at $75M in Q3 2020. 173 funds tracked by Wall St. Rank hold SILK as of Q2 2023.

  • Lord, Abbett & Co reported no remaining Silk Road Medical, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Lord, Abbett & Co sold 795,766 Silk Road Medical, Inc. Common Stock shares in Q2 2023, an estimated $31.1M.
  • Lord, Abbett & Co first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 10 quarters.
  • Lord, Abbett & Co's Silk Road Medical, Inc. Common Stock position peaked at $75M in Q3 2020.
  • 173 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q2 2023.

Based on Lord, Abbett & Co's 13F filing for Q2 2023, filed 14 Aug 2023.